title: Oxytocin ameliorates the immediate myocardial injury in heart transplant through down regulation of the neutrophil dependent myocardial apoptosis.
abstract: Cardiac oxytocin (OT) is structurally identical to that found in the hypothalamus, which thereby indicates that cardiac OT is derived from the same gene and is an active form of OT. The abundance of OT and OT receptors in atrial myocytes shows that, directly and/or via the release of the cardiac hormone atrial natriuretic peptide, OT can regulate the force of cardiac contractions. Previous studies have demonstrated the role of OT in the myocardial inflammatory response. The mechanism by which OT elicits protective myocardial effects in the immediate post-transplantation period is not yet clear, and the role of the early phase inflammatory elements in this mechanism has not yet been studied. As a result, in this study, we have investigated the anti-inflammatory effects of OT on myocardial protection in the immediate post-transplantation period.
  
  
  METHODS
  ADULT MALE ALBINO RATS WERE GROUPED INTO: Sham, Control, and OT-treated groups. The control and treated groups sustained cervical heterotopic heart transplant. Myocardial injury was assessed by measuring: Plasma cardiac troponin I, myocardial proinflammatory cytokines, and histopathological assessment for score of injury, and degree of apoptosis. Myocardial myeloperoxidase, neutrophil infiltration, and neutrophil chemotactant agents, reactive oxygen species, and reactive nitrogen species formation all were measured in the myocardium after 3 hour of reperfusion to assess the neutrophil-dependant myocardial injury and the mechanism involved.
  
  
  RESULTS
  Oxytocin down-regulates the neutrophil chemotactant agents the KC/CXCL1 and MIP-2/CXCL2 which recruit less neutrophil into myocardium, this decrement in myocardial PMN infiltration is associated with less reactive oxygen species and reactive nitrogen species formation in the myocardium after 3 hours of global ischemia reperfusion. These oxytocin-induced down-regulation inflammatory and oxidative processes will end in less myocardial injury through impedance in the post-myocardial ischemia/reperfusion apoptotic process.
  
  
  CONCLUSIONS
  Oxytocin ameliorates myocardial injury in heart transplant through down-regulation the myocardial inflammatory response, reactive oxygen species, and neutrophil-dependant myocardial apoptosis.
authors.affiliation: Surgical Department, Medical College, Kufa University, Najaf, Iraq.
authors.forename: F Fadhil
authors.initials: FF
authors.lastname: Al-Amran
authors.affiliation: Howard University College of Medicine, Medical Department, Washington DC, USA.
authors.forename: Murteza
authors.initials: M
authors.lastname: Shahkolahi
keywords: Heart transplant; neutrophil-dependant myocardial apoptosis; oxytocin
references.citation: J Immunol. 1969 Jan;102(1):93-9
references.pmid: 5765461
references.citation: Life Sci. 1984 Jul 30;35(5):487-91
references.pmid: 6087065
references.citation: Biol Psychol. 2011 Jul;87(3):340-9
references.pmid: 21540072
references.citation: Pediatr Nephrol. 1991 Nov;5(6):733-42
references.pmid: 1662982
references.citation: Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1371-7
references.pmid: 20413731
references.citation: Biochim Biophys Acta. 1976 Aug 24;444(1):192-201
references.pmid: 986186
references.citation: PLoS One. 2010 Oct 26;5(10):e13643
references.pmid: 21048978
references.citation: Basic Res Cardiol. 2010 Mar;105(2):205-18
references.pmid: 20012748
references.citation: Hypertension. 2001 Aug;38(2):292-6
references.pmid: 11509492
references.citation: Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1495-501
references.pmid: 18940936
references.citation: Adv Immunol. 1994;55:97-179
references.pmid: 8304236
references.citation: Scand J Clin Lab Invest. 2011 Nov;71(7):553-62
references.pmid: 21728900
references.citation: Peptides. 2007 Jun;28(6):1170-7
references.pmid: 17537544
references.citation: Clin Chim Acta. 2012 May 18;413(9-10):888-93
references.pmid: 22333672
references.citation: Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11704-9
references.pmid: 9326674
references.citation: Gen Pharmacol. 1998 Oct;31(4):545-52
references.pmid: 9792213
references.citation: Am J Physiol Heart Circ Physiol. 2002 Feb;282(2):H547-55
references.pmid: 11788402
references.citation: Rev Bras Cir Cardiovasc. 2010 Jul-Sep;25(3):388-92
references.pmid: 21103748
references.citation: Chin J Physiol. 2006 Oct 31;49(5):213-22
references.pmid: 17294829
references.citation: Cardiovasc Res. 2012 Apr 1;94(1):105-14
references.pmid: 22298642
references.citation: Biochem J. 1998 Feb 15;330 ( Pt 1):247-54
references.pmid: 9461517
references.citation: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Dec;22(12):1508-10
references.pmid: 19137901
references.citation: J Leukoc Biol. 1997 Jun;61(6):647-53
references.pmid: 9201255
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21437-41
references.pmid: 19934046
references.citation: Age (Dordr). 2013 Aug;35(4):1017-26
references.pmid: 22580631
references.citation: Cardiovasc Res. 2012 May 1;94(2):276-83
references.pmid: 22266751
references.citation: Peptides. 2010 Jul;31(7):1341-5
references.pmid: 20417240
references.citation: Cardiovasc Res. 2007 Mar 1;73(4):761-9
references.pmid: 17261276
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R7-28
references.pmid: 12069927
references.citation: Exp Biol Med (Maywood). 2011 Nov;236(11):1263-73
references.pmid: 21954221
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14558-63
references.pmid: 9826739
references.citation: J Clin Invest. 1989 Oct;84(4):1045-9
references.pmid: 2677047